TMDX250516C100000
- 6.10
- +0.60+10.91%
TransMedics Newsroom
Piper Sandler Reiterates Overweight on TransMedics Group, Raises Price Target to $105
CCORF Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $104
Analysts Are Bullish on These Healthcare Stocks: Organon (OGN), TransMedics Group (TMDX)
TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 33% Share Price Bounce
TransMedics to Report First Quarter 2025 Financial Results on May 8, 2025
Needham Reiterates Hold on TransMedics Groupto Hold
TransMedics Group Analyst Ratings
TD Cowen Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $120
TransMedics Group's OCS Drives Structural Transformation in Liver Transplantation With Increased DCD Liver Utilization
P/E Ratio Insights for TransMedics Group
TransMedics Group: Strong Buy Rating Amidst Robust DCD Market Performance and Growth Prospects
Pharma, MedTech Stocks Bounce Back as Trump Pauses Most Tariffs
Boasting A 16% Return On Equity, Is TransMedics Group, Inc. (NASDAQ:TMDX) A Top Quality Stock?
TransMedics Group And 2 Other Stocks That May Be Trading Below Estimated Value
Express News | Transmedics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Is Transmedics' (TMDX) Long-Term Growth Potential Still Intact?
Piper Sandler Remains a Buy on TransMedics Group (TMDX)
Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock
Needham Maintains TransMedics(TMDX.US) With Hold Rating